Examples of using Hyperlipidaemia in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Decreased appetite Hyperglycaemia Hyperlipidaemia Hypoglycaemia.
Hyperlipidaemia(high cholesterol levels), diabetes and smoking.
High level of lipids(fats)in the blood hyperlipidaemia, raised triglycerides.
Anorexia, diabetes mellitus, hypercholesterolaemia,hypertriglyceridaemia, hyperlipidaemia.
Hypertriglyceridaemia, hypophosphataemia, diabetes mellitus, hyperlipidaemia, hypokalaemia, dehydration, hypocalcaemia.
Lipids: hyperlipidaemia has been identified as an effect associated with the use of bexarotene in clinical studies.
Action should be taken to try to minimise all modifiable risk factors e.g. smoking,hypertension, and hyperlipidaemia.
Common: diabetes mellitus, hypercholesterolaemia, hyperlipidaemia, hypertriglyceridaemia, hyperglycaemia, decreased appetite, hypocalcaemia, hypokalaemia.
Lipodystrophy(including lipohypertrophy, lipodystrophy, lipoatrophy), hypertriglyceridaemia,hypercholesterolaemia, hyperlipidaemia.
Common: hyperglycaemia, hyperlipidaemia, insomnia, synovial disorder, arthrosis, muscular weakness, back pain, breast pain, gynaecomastia.
Similarly the risk/benefit of continued Rapamune therapy should be re-evaluated in patients with severe refractory hyperlipidaemia.
The risk/benefit should be considered in patients with established hyperlipidaemia before initiating an immunosuppressive regimen, including Rapamune.
Amongst the most common adverse reactions reported for Aptivus were gastrointestinal complaints such as diarrhoea andnausea as well as hyperlipidaemia.
Uncommon: hyperlipidaemia, vomiting, abdominal pain, increased aspartate aminotransferase, rash(including maculopapular rash), allergic dermatitis, pruritus.
When prescribing Trizivir, action should be taken to try to minimize all modifiable risk factors e.g. smoking,hypertension, and hyperlipidaemia.
In a 6 week study 129 patients with mixed hyperlipidaemia were randomised to fenofibrate 160 mg plus 3.8 g Cholestagel or fenofibrate alone.
Vascular occlusion adverse events were more frequent with increasing age and in patients with prior history of ischaemia, hypertension,diabetes, or hyperlipidaemia.
Common: hyperglycaemia, hyperlipidaemia, insomnia, synovial disorder, arthrosis, muscular weakness, back pain, breast pain, gynaecomastia.
RA patients have an increased risk for cardiovascular disorders and should have risk factors(e.g. hypertension, hyperlipidaemia) managed as part of usual standard of care.
Bezafibrate was originally labelled as a drug for hyperlipidaemia and used for prevention of cardiovascular diseases hyperlipaemia is an abnormal high concentration of fats in the blood.
Cardiovascular risk RA patients have an increased risk for cardiovascular disorders and should have risk factors(e. g. hypertension, hyperlipidaemia) managed as part of usual standard of care.
Patients with significant risk factors for cardiovascular events(e. g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with parecoxib sodium after careful consideration see section 5.1.
Common: electrolyte imbalance(including hypomagnesaemia, hyperkalaemia, hypokalaemia, hyponatraemia, hypocalcaemia, hypercalcaemia, hyperphosphataemia), diabetes mellitus, hyperglycaemia,hypercholesterolaemia, hyperlipidaemia, hypertriglyceridaemia.
Common: Impaired fasting glucose, hyperlipidaemia, increased blood insulin, increased blood cholesterol, decreased blood sodium, increased blood triglycerides, increased blood glucose, increased or decreased HDL, increased LDL.
Patients with known risk factors for MI, including prior thrombosis, should be closely monitored and action should be taken to try to minimise all modifiable risk factors e.g. smoking,hypertension, and hyperlipidaemia.
Diabetes, hyperlipidaemia, insomnia, hypoaesthesia, ECG abnormal, cough, dyspnoea, skin discolouration, skin lesion, bursitis, proteinuria, renal insufficiency, erectile dysfunction, blood potassium increase, blood TSH increase, lymphocyte count decreased, WBC decrease.
Patients with known risk factors- including prior thrombosis- should be closely monitored, and action should be taken to try to minimize all modifiable risk factors eg. smoking,hypertension, and hyperlipidaemia.
Uncommon: upper respiratory tract infection,diabetes mellitus, hyperlipidaemia, abnormal dreams, hypoaesthesia, disturbance in attention, somnolence, dyspepsia, eructation, increased aspartate aminotransferase, allergic dermatitis, urticaria, dermatitis, night sweats, myalgia, muscle spasms, asthenia.
The following patient groups were represented: elderly(22%), patients with hypertension(35%), diabetes mellitus(29%), ischaemic heart disease and other cardiovascular diseases(7%),chronic pulmonary disease(5%), hyperlipidaemia(22%), depression(5%), radical prostatectomy 9.
Patients with risk factors(e.g. hypertension, hyperlipidaemia, diabetes) or a history of cardiac disease(e.g. prior percutaneous coronary intervention, documented coronary artery disease) should be monitored carefully for clinical signs or symptoms consistent with cardiac dysfunction such as chest pain, shortness of breath, and diaphoresis.